About the Company
We do not have any company description for Telesis Bio Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $TBIO News
Telesis Bio, Inc. (TBIO)
SAN DIEGO, April 18, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated benchtop DNA and mRNA synthesis solutions, today announced a focus in strategy enabled by the ...
Telesis Bio Inc (TBIO) Stock Records 5.78% Quarterly Movement
Based on Telesis Bio Inc (TBIO), the company’s capital structure generated 0.19 points at debt to capital in total, while cash flow to debt ratio is standing at -4.89. The debt to equity ratio resting ...
Telesis Bio announces leadership transition amid new commercial focus
Telesis Bio (TBIO) stock slipped as the company promoted its Chief Operating Officer Eric Esser to the CEO role. Read more ...
Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
SAN DIEGO, March 28, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced ...
Telesis Bio appoints new CEO as founder steps down
Before his tenure at Telesis Bio, Esser held several leadership positions in the life sciences sector. He served as VP of Manufacturing and Supply Chain at Berkeley Lights, Inc., from December ...
Telesis Bio: Q4 Earnings Snapshot
SAN DIEGO — SAN DIEGO — Telesis Bio, Inc. (TBIO) on Thursday reported a loss of $17.7 million in its fourth quarter. On a per-share basis, the San Diego-based company said it had a loss of 61 ...
Telesis Bio, Inc. (TBIO)
SAN DIEGO, March 28, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced ...
Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
SAN DIEGO, March 28, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced, ...
Telesis Bio appoints new CEO as founder steps down
Before his tenure at Telesis Bio, Esser held several leadership positions in the life sciences sector. He served as VP of Manufacturing and Supply Chain at Berkeley Lights, Inc., from December 2019 to ...
Telesis Bio Inc TBIO
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Loading the latest forecasts...